Manuel Battegay
- Infectious Diseases top 1%
- Virology top 0.5%
- Epidemiology top 5%
- Hepatology top 2%
- Emergency Medicine top 2%
- Co-authors
- Amalio TelentiMarkus FleppHansjakob FurrerP FrancioliMatthias EggerBernard HirschelPietro VernazzaMilos Opravil
- Topics
- HIV/AIDS drug development and treatment (9 papers)HIV/AIDS Research and Interventions (8 papers)HIV Research and Treatment (7 papers)
- Partner nations
- SwitzerlandItalyUnited Kingdom
In The Last Decade
Manuel Battegay
15 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Infectious Diseases 1.4k
- Virology 1.1k
- Epidemiology 815
- Hepatology 526
- Emergency Medicine 315
Countries citing papers authored by Manuel Battegay
This map shows the geographic impact of Manuel Battegay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Battegay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Battegay more than expected).
Fields of papers citing papers by Manuel Battegay
This network shows the impact of papers produced by Manuel Battegay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Battegay. The network helps show where Manuel Battegay may publish in the future.
Co-authorship network of co-authors of Manuel Battegay
This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Battegay. A scholar is included among the top collaborators of Manuel Battegay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Battegay. Manuel Battegay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 7 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 58 | |
| 6 | 76 | |
| 7 | 95 | |
| 8 | 80 | |
| 9 | 33 | |
| 10 | 10 | |
| 11 | Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Studybreakdown → | 692 |
| 12 | 31 | |
| 13 | 172 | |
| 14 | 13 | |
| 15 | Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort studybreakdown → | 772 |
| 16 | 39 | |
| 17 | [Calcium carbonate for the treatment of hyperphosphatemia in chronic hemodialysis patients]. | 1 |
About Manuel Battegay
Manuel Battegay is a scholar working on Virology, Infectious Diseases and Complementary and Manual Therapy, having authored 17 papers that have together received 2.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (8 papers) and HIV Research and Treatment (7 papers). The work is most often cited by research in Virology (1.1k citations), Infectious Diseases (1.4k citations) and Hepatology (526 citations). Manuel Battegay has collaborated with scholars based in Switzerland, Italy and United Kingdom. Frequent co-authors include Amalio Telenti, Markus Flepp, Hansjakob Furrer, P Francioli, Matthias Egger, Bernard Hirschel, Pietro Vernazza, Milos Opravil, Bruno Ledergerber and Rainer Weber. Their work appears in journals such as New England Journal of Medicine, The Lancet and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.